A post-mortem study on striatal dopamine receptors in Parkinson's disease

Striatal dopamine D1 and D2 receptors were investigated in 49 patients with Parkinson's disease (PD) and 33 age-matched controls with [3H]SCH 23390 and [3H]spiroperidol as ligands respectively. A full Scatchard analysis giving Bmax and Kd values was performed. In the caudate nucleus, a small but significant decrease in the number of D1 and D2 receptors was seen, whereas in the putamen the number of dopamine receptors was unchanged. Treatment with neuroleptics was found to increase the number of D2 receptors both in the caudate nucleus and putamen. The number of neither D1 nor D2 receptors correlated neither with the duration of disease or levodopa treatment of the patients nor with the post-mortem delay or storage time of the samples. Furthermore, no association was found between either D1 or D2 receptor number and clinical variables of the patients. The activity of choline acetyltransferase (ChAT) was found to be unchanged in the striatum, whereas a marked decline was seen in the hippocampus and cortical areas, indicating that intrinsic striatal cholinergic neurons are not affected in PD. The present results suggest that there is a modest decline in the number of striatal dopamine D2 receptors in advanced patients with PD at the end stage of the disease.

[1]  J. Rinne,et al.  Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[2]  L L Iversen,et al.  Increased brain dopamine and dopamine receptors in schizophrenia. , 1982, Archives of general psychiatry.

[3]  S. Snyder,et al.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.

[4]  S. Snyder,et al.  Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.

[5]  F. Fonnum,et al.  A rapid radiochemical method for the determination of choline acetyltransferase , 1975, Journal of neurochemistry.

[6]  P J Whitehouse,et al.  Effects of Postmortem Delay and Temperature on Neurotransmitter Receptor Binding in a Rat Model of the Human Autopsy Process , 1984, Journal of neurochemistry.

[7]  J. Fields,et al.  Neurotransmitter receptor alterations in Parkinson's disease. , 1977, Life sciences.

[8]  S. Snyder,et al.  Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.

[9]  B. Scatton.  Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. , 1982, Life sciences.

[10]  Y. Agid,et al.  Dopamine D‐1 Receptor and Cyclic AMP‐Dependent Phosphorylation in Parkinson's Disease , 1987, Journal of neurochemistry.

[11]  Y Agid,et al.  [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. , 1984, European journal of pharmacology.

[12]  M. Poulter,et al.  INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA , 1978, The Lancet.

[13]  J. Rinne,et al.  Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease , 1989, Brain Research.

[14]  E. Perry,et al.  Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[15]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.

[16]  P. Seeman,et al.  Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains , 1978, Nature.

[17]  K. Någren,et al.  PET demonstrates different behaviour of striatal dopamine D‐1 and D‐2 receptors in early Parkinson's disease , 1990, Journal of neuroscience research.

[18]  Mohamed N. Hassan,et al.  Dopamine receptors in Parkinson's disease , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[19]  Päivi Marjamäki,et al.  Age-dependent decline in human brain dopamine D1 and D2 receptors , 1990, Brain Research.

[20]  A. Laihinen,et al.  Function of dopamine receptors in Parkinson's disease , 1986, Neurology.

[21]  Y. Agid,et al.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia , 1982, Brain Research.

[22]  Philip Seeman,et al.  Dopamine D2 receptor density remains constant in treated Parkinson's disease , 1986, Annals of neurology.

[23]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[24]  Frank Roels,et al.  Autoradiographic localization of D1 and D2 dopamine receptors in the human brain , 1988, Neuroscience Letters.

[25]  J. Rinne,et al.  Dopamine D-1 receptors in the parkinsonian brain , 1985, Brain Research.

[26]  J. Marcusson,et al.  Age‐Correlated Loss of Dopaminergic Binding Sites in Human Basal Ganglia , 1982, Journal of neurochemistry.

[27]  P. Spano,et al.  [3H]haloperidol and [3H]spiroperidol receptor binding after striatal injection of kainic acid , 1978, Neuroscience Letters.

[28]  Y. Agid,et al.  Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects. , 1985, European journal of pharmacology.

[29]  E. Bird,et al.  Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia , 1988, Synapse.

[30]  Philip Seeman,et al.  Human brain dopamine receptors in children and aging adults , 1987, Synapse.

[31]  Y. Agid,et al.  D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy , 1988, Journal of the Neurological Sciences.

[32]  G. Vauquelin,et al.  D2 dopamine receptors in the human brain: heterogeneity based on differences in guanine nucleotide effect on agonist binding, and their presence on corticostriatal nerve terminals , 1989, Brain Research.

[33]  Y. Wong,et al.  Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors. , 1978, Life sciences.

[34]  J. Joyce,et al.  Striatal topography of D-2 receptors correlates with indexes of cholinergic neuron localization , 1985, Neuroscience Letters.